Reconstitution applies to lyophilized (freeze-dried) research-grade semaglutide
Semaglutide is administered either as a once-weekly subcutaneous injection (Ozempic 0.252 mg, Wegovy 0.252.4 mg) or as a daily oral tablet (Rybelsus 314 mg)
The card is not available to Aetna Medicare Advantage or Medicaid members under federal anti-kickback rules
What This New Study Found Between Semaglutide (Ozempic, Wegovy), Tirzepatide (Mounjaro, Zepbound), and Stroke Risk A new cohort study published July 2025 in JAMA Network Open followed over 60,000 adults with both type 2 diabetes and obesity
A structured maintenance plan can help reduce regain risk, but no approach guarantees complete stability
Checking with insurers directly is crucial to determine coverage